Careers  |  Sign In  |  Register  |   Twitter

New Drug to Treat Constipation Passes Late Stage Study

According to Reuters, a new drug developed by Synergy Pharmaceuticals, plecanatide, has succeeded in a late stage study.The drug is used to treat constipation and showed in trials that patients responded better to treatment with plecanatide than those patients on the placebo. According to Synergy, plecanatide is an analog to the natural GI hormone Uroguanylin which plays a role in normal functioning of the digestive tract and bowels. Synergy is hopeful that plecanatide will receive regulatory approval in the fourth quarter.

 

Read the article on Reuters.

Read the trial on ClinicalTrials.gov.